GKSL Share Price | Gujarat Kidney & Super Speciality Ltd Stock Analysis & Recommendation

Q: Should I buy, sell or hold Gujarat Kidney & Super Speciality Ltd?

Based on the current information regarding Gujarat Kidney & Super Speciality Ltd, there are compelling reasons to consider buying the stock, but also some significant risks to weigh.On the positive side, the company demonstrates a strong ability to service its debt, highlighted by a low Debt to EBITDA ratio of 1.08 times. This suggests financial stability. Additionally, the company has shown impressive growth in operating profit, with an 80.69% increase reported recently, and its net sales for the latest six months have reached Rs 64.87 crore. The positive trend in profitability is further supported by a 66.99% growth in profit after tax over the same period, and the company has delivered positive results for the last two consecutive quarters.However, there are notable risks to consider. The company's return on equity (ROE) stands at 6.1, indicating a relatively low return compared to its valuation, which is seen as expensive with a Price to Book Value of 5.4. Furthermore, the lack of investment from domestic mutual funds, which hold 0% of the company, could be a red flag. This might suggest that institutional investors are not comfortable with the current valuation or the business's prospects.In summary, if you are optimistic about the company's recent performance and believe in its growth potential, it may be a good time to buy. However, if you are cautious about high valuations and the lack of institutional support, holding or selling might be prudent. Ultimately, your decision should align with your investment strategy and risk tolerance.

Q: What does Gujarat Kidney do?

Overview:Gujarat Kidney & Super Speciality Ltd operates in the hospital industry and is categorized as a micro-cap company.History:The company was incorporated in 2019 under the name Vihaan Medicare Private Limited and later changed its name to Gujarat Kidney and Super Speciality Private Limited in September 2023. The most recent quarterly results reported net sales and profit for June 2026.Financial Snapshot:Net Sales: 34 Cr (Quarterly Results - Jun 2026) Net Profit: 5 Cr (Quarterly Results - Jun 2026) Market Cap: INR 1,274 Cr (Micro Cap)Key Metrics:P/E: 79.00 Industry P/E: 67 Dividend Yield: 0.00% Debt-Equity: -0.11 Return on Equity: 6.14% Price to Book: 5.02 Contact Details:Details: No Company Details Available Registrar Address: Not available.

Q: Who are the peers of the Gujarat Kidney?

Peers: The peers of Gujarat Kidney are Indrapr.Medical, Dr Agarwal's Eye, KMC Speciality, Shalby, GPT Healthcare, Asarfi Hospital, Unihealth Hosp, Chandan Healthca, and Aprameya Enginee.Quality Snapshot: Excellent management risk is observed at GPT Healthcare and Aprameya Enginee, while Average management risk is found at Indrapr.Medical, Dr Agarwal's Eye, KMC Speciality, Asarfi Hospital, Unihealth Hosp, and Chandan Healthca, and the rest. Below Average management risk is noted at Shalby. Growth is Excellent at Unihealth Hosp and Chandan Healthca, Good at Indrapr.Medical, Dr Agarwal's Eye, KMC Speciality, Asarfi Hospital, and the rest, while Average growth is seen at Shalby and the rest. Capital Structure is Excellent at Indrapr.Medical, KMC Speciality, and GPT Healthcare, Good at Shalby, Asarfi Hospital, and Aprameya Enginee, while Average capital structure is noted at Dr Agarwal's Eye.Return Snapshot: KMC Speciality has the highest 1-year return at 97.77%, while Shalby has the lowest at -20.36%, with Gujarat Kidney's 1-year return being N/A. Additionally, Shalby is the only peer with a negative six-month return.

Mojo Score Change: Gujarat Kidney has changed its score on 21 Sep 2026. Click here to unlock latest mojo score!

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

86.83 k (26.00%) Volume

Shareholding (Jun 2026)

FII

4.88%

Held by 12 FIIs

DII

0.56%

Held by 0 DIIs

Promoter

71.45%

Which are the latest news on Gujarat Kidney?

24-Sep-2026

Gujarat Kidney & Super Speciality Ltd Downgraded to Hold Amid Mixed Technical and Valuation Signals
Gujarat Kidney & Super Speciality Ltd Sees Shift in Technical Momentum Amid Strong Returns

Why is Gujarat Kidney & Super Speciality Ltd falling/rising?

06-Sep-2026

As of 05-Sep, Gujarat Kidney & Super Speciality Ltd's stock price is at 172.65, reflecting a 0.52% increase. The stock has shown strong performance with a 68.03% year-to-date rise, outperforming the Sensex, and is close to its 52-week high, supported by solid financial health despite a decline in investor participation.

View full answer

Should I buy, sell or hold Gujarat Kidney & Super Speciality Ltd?

05-Sep-2026

What does Gujarat Kidney do?

01-Sep-2026

Gujarat Kidney & Super Speciality Ltd, a micro-cap company established in 2019, operates in the hospital industry and reported net sales of 34 Cr and a net profit of 5 Cr for June 2026. The company has a market cap of INR 1,274 Cr and key financial metrics include a P/E ratio of 79.00 and a return on equity of 6.14%.

View full answer

Who are the peers of the Gujarat Kidney?

01-Sep-2026

Peers of Gujarat Kidney include Indrapr.Medical, Dr Agarwal's Eye, KMC Speciality, Shalby, GPT Healthcare, Asarfi Hospital, Unihealth Hosp, Chandan Healthcare, and Aprameya Enginee. KMC Speciality has the highest 1-year return at 97.77%, while Shalby has the lowest at -20.36%.

View full answer

How big is Gujarat Kidney?

01-Sep-2026

As of 31st August, Gujarat Kidney & Super Speciality Ltd has a market capitalization of 1,274.00 Cr, with recent Net Sales of 101.05 Cr and a Net Profit of 15.83 Cr.

View full answer

When is the next results date for Gujarat Kidney & Super Speciality Ltd?

07-Aug-2026

The next results date for Gujarat Kidney & Super Speciality Ltd is 14 August 2026.

View full answer

Compare Gujarat Kidney with Similar Stocks

Shalby GPT Healthcare Dr Agarwal's Eye

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.08 times

Low Debt Company with Strong Long Term Fundamental Strength

With a growth in Operating Profit of 80.69%, the company declared Very Positive results in Jun 26

With ROE of 6.1, it has a Very Expensive valuation with a 5.3 Price to Book Value

Despite the size of the company, domestic mutual funds hold only 0% of the company

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Hospital

Market cap

INR 1,361 Cr (Micro Cap)

P/E

85.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.11

Return on Equity

6.14%

Price to Book

5.35

Revenue and Profits:

Net Sales:

34 Cr

(Quarterly Results - Jun 2026)

Net Profit:

5 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

37.77%

6 Months

71.04%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Gujarat Kidney for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

Gujarat Kidney & Super Speciality Ltd Downgraded to Hold Amid Mixed Technical and Valuation Signals

Gujarat Kidney & Super Speciality Ltd, a micro-cap player in the hospital sector, has seen its investment rating downgraded from Buy to Hold as of 21 September 2026. This revision reflects a nuanced assessment across four key parameters: quality, valuation, financial trend, and technical indicators. While the company continues to demonstrate strong financial performance and operational resilience, evolving technical signals and valuation concerns have tempered the overall outlook.

Read full news article

Gujarat Kidney & Super Speciality Ltd Sees Shift in Technical Momentum Amid Strong Returns

Gujarat Kidney & Super Speciality Ltd, a micro-cap player in the hospital sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish trend. This change comes alongside impressive stock returns that have outpaced the broader Sensex, signalling evolving market dynamics and investor sentiment.

Read full news article

Broad-Based Technical Strength Lifts Gujarat Kidney & Super Speciality Ltd to 52-Week High of Rs 186.85

With a decisive break above Rs 186.85 on 21 Sep 2026, Gujarat Kidney & Super Speciality Ltd has reached a fresh 52-week and all-time high, propelled by a confluence of strong technical signals and sustained price momentum over recent sessions.

Read full news article

Announcements

Reg. 34 (1) Annual Report.

19-Sep-2026 | Source : BSE

Corrigendum -Annual Report 2026

Announcement under Regulation 30 (LODR)-Newspaper Publication

04-Sep-2026 | Source : BSE

Newspaper Publication

Reg. 34 (1) Annual Report.

03-Sep-2026 | Source : BSE

Revised Annual Report

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

12.54

Debt to EBITDA (avg)

0.92

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.74

Tax Ratio

20.82%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

5.44%

ROCE (avg)

26.45%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

5.35

EV to EBIT

59.47

EV to EBITDA

49.09

EV to Capital Employed

5.87

EV to Sales

16.13

PEG Ratio

Dividend Yield

ROCE (Latest)

9.87%

ROE (Latest)

6.14%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

Bearish

Bollinger Bands

Mildly Bullish

KST

Dow Theory

Bullish

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Jun 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (0.0%)

FIIs

Held by 12 FIIs (4.88%)

Promoter with highest holding

Pragnesh Yashwantsinh Bharpoda (38.16%)

Highest Public shareholder

Khandelwal Finance Private Limited (1.67%)

Individual Investors Holdings

10.64%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 0.00% vs -5.33% in Mar 2026",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 48.91% vs -41.20% in Mar 2026",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9.24",
          "val2": "9.24",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.00",
          "val2": "1.57",
          "chgp": "91.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.35",
          "val2": "0.50",
          "chgp": "-30.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "2.04",
          "val2": "1.37",
          "chgp": "48.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "32.47%",
          "val2": "16.99%",
          "chgp": "15.48%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "21.09",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "10.42",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.36",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "6.20",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "49.41%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "30.85",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "14.56",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.65",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "8.53",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "47.20%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "40.10",
          "val2": "35.17",
          "chgp": "14.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "16.14",
          "val2": "15.45",
          "chgp": "4.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.15",
          "val2": "0.53",
          "chgp": "116.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "9.90",
          "val2": "9.11",
          "chgp": "8.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "40.25%",
          "val2": "43.93%",
          "chgp": "-3.68%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ

Jun'26

Mar'26

Change(%)

Net Sales

9.24

Operating Profit (PBDIT) excl Other Income

3.00

1.57

91.08%

Interest

0.35

0.50

-30.00%

Exceptional Items

0.00

Standalone Net Profit

2.04

1.37

48.91%

Operating Profit Margin (Excl OI)

32.47%

16.99%

15.48%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2026 is 0.00% vs -5.33% in Mar 2026

Standalone Net Profit

QoQ Growth in quarter ended Jun 2026 is 48.91% vs -41.20% in Mar 2026

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Change(%)

Net Sales

21.09

Operating Profit (PBDIT) excl Other Income

10.42

Interest

0.36

Exceptional Items

0.00

Standalone Net Profit

6.20

Operating Profit Margin (Excl OI)

49.41%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Dec'25

Dec'25

Change(%)

Net Sales

30.85

Operating Profit (PBDIT) excl Other Income

14.56

Interest

0.65

Exceptional Items

0.00

Standalone Net Profit

8.53

Operating Profit Margin (Excl OI)

47.20%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

40.10

35.17

14.02%

Operating Profit (PBDIT) excl Other Income

16.14

15.45

4.47%

Interest

1.15

0.53

116.98%

Exceptional Items

0.00

Standalone Net Profit

9.90

9.11

8.67%

Operating Profit Margin (Excl OI)

40.25%

43.93%

-3.68%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About Gujarat Kidney & Super Speciality Ltd

Gujarat Kidney & Super Speciality Ltd

Micro Cap

Hospital

Gujarat Kidney And Super Speciality Limited was incorporated under the name and style of `Vihaan Medicare Private Limited', a private limited company, dated December 20, 2019 issued by the Registrar of Companies, Central Registration Centre. Subsequently, the Company name was changed to `Gujarat Kidney and Super Speciality Private Limited' and a fresh certificate of incorporation dated September 13, 2023 was issued by the Registrar of Companies, Gujarat at Ahmedabad.

Company Coordinates

No Company Details Available

Footer loading